PharmaSGP Holding SE provided earnings guidance for the fiscal year 2022. For the year, the company expects revenue to be between EUR 78 million to EUR 82 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.2 EUR | -4.31% |
|
-2.63% | -1.33% |
05-28 | PharmaSGP Holding SE Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-29 | PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.33% | 298M | |
+56.86% | 815B | |
+43.90% | 641B | |
-6.57% | 352B | |
+17.32% | 314B | |
+9.94% | 303B | |
+16.08% | 242B | |
+2.29% | 224B | |
+13.96% | 218B | |
+7.98% | 168B |
- Stock Market
- Equities
- PSG Stock
- News PharmaSGP Holding SE
- PharmaSGP Holding SE Provides Earnings Guidance for the Fiscal Year 2022